Flora Growth Corp (FLWPF) Stock Analysis — June 2026
Executive Summary
Flora Growth Corp (OTC: FLWPF) is a licensed producer (lp) company currently priced at $26.24 per share with a market capitalization of $3.18B. The company generates trailing twelve-month revenue of $383.3M with a gross margin of 7.2% and year-over-year revenue growth of +0.50%. The stock trades on the OTC exchange in the Canadian market, and is positioned as a large-cap player within the cannabis sector.
Key Takeaways
Flora Growth Corp has a market cap of $3.18B, making it a large-cap cannabis company listed on the OTC.
Trailing twelve-month revenue is $383.3M with year-over-year growth of +0.5%. Modest growth indicates steady but unspectacular top-line expansion.
The company's gross margin stands at 7.2%. Low or negative margins raise questions about pricing power and cost structure.
Flora Growth Corp holds $464.5M in cash against $371.1M in debt, resulting in a net cash position of $93.5M and an estimated 2.1 months of cash runway.
The stock trades at a P/S ratio of 3.12x and EV/Revenue of 20.09x. Multiples are in a moderate range for cannabis stocks.
At $26.24, the stock trades at 45% of its 52-week range ($16.09 – $38.80). The stock is trading mid-range, offering a balanced risk-reward profile.
The annual share dilution rate is 26.5%. High dilution is eroding shareholder value and is a significant risk factor.
Flora Growth Corp Company Overview
Flora Growth Corp (OTC: FLWPF) is a licensed producer (lp) company currently trading at $26.24 per share with a market capitalization of $3.18B. The stock gained +9.78% in the most recent trading session on volume of 25.2M shares. Flora Growth Corp is headquartered in Canada and employs approximately 2,464 people. As a participant in the licensed producer (lp) segment, the company operates within one of the most dynamic and rapidly evolving sectors of the North American economy.
On the revenue front, Flora Growth Corp generated $383.3M in trailing twelve-month (TTM) revenue, reflecting year-over-year growth of +0.5%. This growth rate is outpacing the LP sector average of 0.0%. Flora Growth Corp is marginally profitable at the gross level with a 7.2% gross margin, suggesting the company is covering its direct costs of goods sold but may face challenges scaling to full profitability. Revenue trends in the cannabis industry are closely watched by analysts, as the sector continues to navigate pricing compression, oversupply dynamics in certain markets, and the ongoing burden of IRS Section 280E, which prevents cannabis businesses from deducting ordinary business expenses at the federal level.
Financial Analysis
Flora Growth Corp generated $383.3M in trailing twelve-month revenue, reflecting year-over-year growth of +0.50%. The company's gross margin of 7.2% translates to approximately $27.6M in gross profit over the trailing twelve months. This margin profile places Flora Growth Corp in a challenging margin position, where the company covers its direct costs but faces pressure on operational profitability.
Revenue momentum is a critical metric for cannabis companies, as the industry continues to evolve through shifts in consumer demand, regulatory changes, and competitive dynamics. Flora Growth Corp's modest growth of +0.50% suggests steady but measured expansion, which may reflect the challenges of growing in a maturing cannabis market environment where pricing pressure and competition are intensifying. The cannabis industry's profitability dynamics are heavily influenced by IRS Section 280E, which prevents plant-touching operators from deducting ordinary business expenses for federal income tax purposes, effectively creating tax rates that can exceed 70% of gross profit.
Valuation Analysis
From a valuation perspective, Flora Growth Corp trades at a price-to-sales (P/S) ratio of 3.12x, which is above the sector median of 0.00x, suggesting the market is pricing in higher growth expectations or a premium for Flora Growth Corp's market position. The enterprise value-to-revenue (EV/Revenue) multiple stands at 20.09x. Cannabis stock valuations have compressed significantly from their 2021 highs, and current multiples reflect a more mature market environment where investors demand clear paths to profitability. For context, the broader LP sector contains 24 publicly traded companies tracked by CannaCap, and Flora Growth Corp's valuation should be considered within the context of its specific growth profile and competitive positioning.
At a price-to-sales ratio of 3.12x and an enterprise value-to-revenue multiple of 20.09x, Flora Growth Corp's valuation reflects the market's current assessment of the company's growth potential and risk profile. Enterprise value — calculated as market capitalization plus total debt minus cash — stands at approximately $3.08B, providing a more complete picture of the company's total valuation when accounting for balance sheet items. Investors should compare these multiples against both direct sector peers and historical ranges to determine whether FLWPF is trading at a premium or discount.
Balance Sheet Deep Dive
The company holds a net cash position of $93.5M, with $464.5M in cash and equivalents against $371.1M in total debt. This provides a financial cushion of approximately 2.1 months of operating runway at current burn rates. Access to capital remains a persistent challenge for cannabis companies, particularly plant-touching operators that are excluded from traditional banking services and institutional lending. Many cannabis companies have turned to sale-leaseback transactions, private placements, and at-the-market (ATM) equity offerings to fund operations. Flora Growth Corp's balance sheet should be evaluated with these industry-specific constraints in mind.
Flora Growth Corp maintains a net cash position of $93.5M, which represents a meaningful financial cushion. With $464.5M in cash and equivalents against $371.1M in total debt, the company has an estimated 2 months of operating runway at the current rate of cash consumption. This runway provides management with flexibility to pursue organic growth initiatives, evaluate strategic M&A opportunities, and navigate the capital-constrained cannabis industry without immediate pressure to raise dilutive equity capital.
The company's annual share dilution rate of 26.5% is significantly elevated, indicating heavy reliance on equity issuance to fund operations. This level of dilution erodes existing shareholder value at a concerning pace and suggests the company's operations are not yet self-funding. With 121.1M shares currently outstanding, any additional equity issuance directly impacts per-share metrics including earnings per share, book value per share, and ownership percentage.
Licensed Producer (LP) Sector Context
Within the Licensed Producer (LP) sector, Flora Growth Corp ranks #1 out of 24 companies by market capitalization, commanding a 46.8% share of the sector's total market cap of $6.79B. Licensed Producers are cannabis companies authorized by Health Canada to cultivate and sell cannabis. LPs were the primary vehicle for Canada's legal recreational market, which launched in October 2018, and many have expanded internationally. The largest company in the sector by market cap is Flora Growth Corp (FLWPF) at $3.18B, followed by Cronos Group (CRON) at $1.07B.
By revenue, Flora Growth Corp ranks #2 in its sector with $383.3M in trailing twelve-month sales. The sector's top revenue generator is Tilray Brands at $858.3M. Flora Growth Corp's gross margin of 7.2% compares to a sector average of 6.0%, placing it above the peer group midpoint. Revenue growth of +0.5% year-over-year demonstrates the company's ability to expand its top line in a competitive market.
What distinguishes Flora Growth Corp within the Licensed Producer (LP) space includes the largest company by market cap in its sector; a large workforce of 2,464 employees. These characteristics help define the company's competitive positioning and investment thesis relative to the 23 other LP companies tracked by CannaCap. Investors comparing cannabis stocks within this sector should consider not just valuation multiples, but also balance sheet strength, management execution, and geographic or product diversification.
Historical Price Performance
Flora Growth Corp (FLWPF) currently trades at $26.24, which places the stock at approximately 45% of its 52-week trading range. Over the past twelve months, FLWPF has traded as high as $38.80 and as low as $16.09, representing a 141.1% spread between the yearly high and low. The current price sits 32.4% below the 52-week high and 63.1% above the 52-week low. This range provides important context for understanding the stock's recent volatility and where current levels fall within the broader price history.
In the most recent trading session, FLWPF rose +9.78% from a previous close of $23.90 to $26.24, on volume of 25.2M shares. This positive session represents a significant single-day move that may have been driven by company-specific news, sector-wide sentiment, or broader market dynamics. The stock has 121,063,784 shares outstanding, giving it a fully diluted market capitalization that investors should factor into their analysis alongside the current $3.18B market cap figure.
Cannabis stocks have historically exhibited significant price volatility driven by regulatory developments, earnings surprises, and shifts in market sentiment toward the sector. FLWPF is trading in the middle of its 52-week range, which suggests the stock has room to move in either direction based on fundamental catalysts. Historical price levels should be considered alongside fundamental data — including revenue trends, margin improvement, and balance sheet health — to form a complete investment thesis.
Investment Thesis
A balanced framework for evaluating Flora Growth Corp (FLWPF) as a potential investment, considering both the upside catalysts and downside risks based on the company's current financial data and industry positioning.
Revenue stabilization and potential for operational improvements could reignite top-line growth. With TTM revenue of $383.3M, even modest gains in market share or pricing power could meaningfully impact the company's financial trajectory and investor sentiment toward FLWPF.
Positive gross margin of 7.2% with room for expansion as the company scales operations and optimizes its cost structure. Industry-wide margin improvements driven by state-level regulatory maturation and potential federal reform (particularly the elimination of Section 280E) could provide a significant tailwind.
Net cash position of $93.5M provides financial flexibility for strategic acquisitions, organic expansion, and weathering industry downturns. With approximately 2 months of cash runway, Flora Growth Corp has a meaningful buffer to execute on its business plan without immediate dilutive capital raises.
Intensifying competition from both legal operators and the persistent illicit market could pressure Flora Growth Corp's revenue growth and margins. The cannabis industry remains highly fragmented, and market share gains are becoming increasingly difficult as more states award licenses and new competitors enter the market.
Aggressive share dilution at 26.5% annually is eroding existing shareholder value at a concerning rate. Even if the company grows revenue and improves operations, the per-share economics may not improve proportionally if the share count continues to expand at this pace.
Regulatory uncertainty remains the single largest risk for Flora Growth Corp and all cannabis investments. Federal prohibition in the United States creates ongoing challenges including Section 280E tax burdens, limited interstate commerce, and the risk of enforcement actions. State-level regulatory changes, licensing moratoriums, and social equity requirements add additional layers of unpredictability that can materially impact the company's operations and growth plans.
Risk Factors
Key risks that investors should consider before investing in Flora Growth Corp (FLWPF). This is not an exhaustive list, and investors should conduct their own due diligence.
Regulatory & Legal Risk
Cannabis remains a Schedule I controlled substance under federal law, creating fundamental legal uncertainty for Flora Growth Corp and all plant-touching cannabis operators. Changes in federal enforcement policy, state regulatory frameworks, or local ordinances could materially impact the company's operations, licensing, and financial performance. The evolving patchwork of state regulations creates compliance complexity and limits the ability to operate across state lines.
Share Dilution Risk
Flora Growth Corp's annual dilution rate of 26.5% indicates ongoing equity issuance that erodes existing shareholder ownership. With 121.1M shares currently outstanding, continued dilution could result in additional shares being issued through at-the-market (ATM) offerings, warrant exercises, stock-based compensation, or convertible debt conversions. Investors should monitor the fully diluted share count and factor dilution into any per-share valuation analysis.
Balance Sheet & Liquidity Risk
With $464.5M in cash against $371.1M in total debt and an estimated 2 months of cash runway, Flora Growth Corp faces potential liquidity constraints. The company may need to secure additional financing through equity raises (which dilute shareholders), debt issuance (which increases financial risk), or asset sales (which may reduce operational capacity). Cannabis companies' limited access to traditional banking further constrains available financing options.
Section 280E Tax Burden
Under IRS Section 280E, cannabis businesses are prohibited from deducting ordinary business expenses for federal income tax purposes. This effectively results in tax rates that can exceed 70% of gross profit for plant-touching operators, significantly reducing cash flow available for reinvestment and debt service. While potential rescheduling could eliminate this burden, the timeline and outcome remain uncertain, and Flora Growth Corp's profitability metrics should be evaluated with this tax overhang in mind.
Market & Competition Risk
The cannabis industry faces pricing pressure from oversupply in mature markets, competition from the illicit market (which avoids regulatory costs and taxation), and evolving consumer preferences. Flora Growth Corp competes for market share against both established operators and well-funded new entrants. Price compression in key markets has squeezed margins across the industry, and any worsening of these trends could materially impact the company's revenue and profitability outlook.
Frequently Asked Questions
Common questions about Flora Growth Corp (FLWPF) stock, answered with real-time data from Cannabismarketcap.
What is Flora Growth Corp's (FLWPF) stock price today?
Flora Growth Corp (FLWPF) stock is currently trading at $26.24 per share on the OTC exchange. This represents a daily gain of +9.78% ($2.34) from the previous closing price of $23.90. Over the past 52 weeks, FLWPF has traded between a low of $16.09 and a high of $38.80, placing the current price at approximately -32% from its annual high. The stock has a market capitalization of $3.18B, making it one of the larger cannabis companies tracked by Cannabismarketcap. Flora Growth Corp operates in the LP sector, serving the broader cannabis industry.
What is Flora Growth Corp's market capitalization?
Flora Growth Corp (FLWPF) has a current market capitalization of $3.18B, calculated by multiplying its 121.1M shares outstanding by the current stock price of $26.24. Market capitalization is a key measure of a company's total equity value as perceived by the public market, and it places Flora Growth Corp among the large-cap cannabis companies tracked on Cannabismarketcap. For context, the enterprise value (market cap plus debt minus cash) stands at $3.08B, which accounts for the company's balance sheet structure. Investors often use market cap alongside revenue and profitability metrics to assess relative valuation within the cannabis sector.
Is Flora Growth Corp profitable?
Flora Growth Corp (FLWPF) currently reports a gross margin of 7.2%, which means the company retains 7.2 cents of every revenue dollar after direct costs of goods sold. On trailing twelve month revenue of $383.3M, this translates to an estimated gross profit of approximately $27.6M. Profitability is a critical factor in the cannabis industry, where many companies are still investing heavily in growth and regulatory compliance. Investors should review the full income statement, cash flow trends, and operating expense breakdown on Cannabismarketcap for a complete picture of Flora Growth Corp's financial health.
What is Flora Growth Corp's annual revenue?
Flora Growth Corp (FLWPF) reports trailing twelve month (TTM) revenue of $383.3M, reflecting the total sales generated by the company over the most recent four quarters. Revenue has changed +0.50% year-over-year, indicating growth momentum relative to the prior period. The current price-to-sales ratio is 3.12x, which means investors are paying $3.12 for every $1 of annual revenue — a moderate valuation in the context of the cannabis sector. Revenue is one of the most closely watched metrics for cannabis companies, as many are still scaling operations in a rapidly evolving regulatory environment. View the full income statement and quarterly revenue breakdown on Cannabismarketcap for detailed trend analysis.
What are Flora Growth Corp's key financial metrics?
Flora Growth Corp (FLWPF) reports several important financial metrics that investors track closely. The company has a market capitalization of $3.18B, trailing twelve month revenue of $383.3M, and a gross margin of 7.2%. On the balance sheet, Flora Growth Corp holds $464.5M in cash and equivalents against $371.1M in total debt, resulting in a debt-to-market-cap ratio of 0.12x. The price-to-sales ratio stands at 3.12x, while the enterprise value to revenue multiple is 20.09x. With 121.1M shares outstanding and a dilution rate of 26.5%, investors should consider both the fundamental financial performance and share structure when evaluating FLWPF.
How many employees does Flora Growth Corp have?
Flora Growth Corp currently employs approximately 2,464 people across its operations. As a LP cannabis company headquartered in Canada, its workforce supports activities spanning related business functions. Based on trailing twelve month revenue of $383.3M, this equates to approximately $155.6K in revenue per employee, which is a useful efficiency metric for comparing operational productivity across cannabis companies. Employee count is an important indicator of a company's operational scale and its capacity for growth in an industry that remains highly labor-intensive due to regulatory requirements.
What exchange is FLWPF listed on?
Flora Growth Corp trades under the ticker symbol FLWPF on the OTC exchange, and the stock is denominated in US dollars (USD). Shares can typically be purchased through most standard brokerage accounts, though some brokers may charge additional fees for OTC-listed securities. The stock sees average daily trading volume of approximately 25.2M shares, which is an important consideration for liquidity and the ability to enter or exit positions without significant price impact.
What sector is Flora Growth Corp in?
Flora Growth Corp is classified as a LP company within the cannabis industry, meaning it is a licensed producer of cannabis, typically operating under a national framework for cultivation and distribution. The LP sector is a key segment of the cannabis market, and investors often compare companies within the same sector to identify relative outperformers. You can compare FLWPF with other LP stocks on Cannabismarketcap's sector page to see how it ranks on metrics like market cap, revenue, and margins.
What is Flora Growth Corp's gross margin?
Flora Growth Corp (FLWPF) has a gross margin of 7.2%, which represents the percentage of revenue the company retains after paying for the direct cost of goods sold. On trailing twelve month revenue of $383.3M, this translates to an estimated gross profit of approximately $27.6M. Gross margin is a critical profitability indicator in the cannabis industry, where companies face unique cost pressures from regulatory compliance, testing requirements, and the tax burden of IRC Section 280E (which prevents cannabis companies from deducting standard business expenses). A thin gross margin like Flora Growth Corp's suggests the company has pricing power and operational efficiency relative to peers.
How does FLWPF compare to other cannabis stocks?
You can compare Flora Growth Corp (FLWPF) side-by-side with any cannabis stock on Cannabismarketcap using the dedicated comparison tool. Key comparison metrics include market cap ($3.18B), trailing twelve month revenue ($383.3M), gross margin (7.2%), and price-to-sales ratio (3.12x). Flora Growth Corp sits in the LP sector, so the most relevant peer comparisons would be against other LP companies, though cross-sector comparisons can also reveal interesting insights about relative valuation. Visit the rankings page to see where FLWPF stands across all cannabis companies on metrics like revenue growth (+0.50% YoY), cash position ($464.5M), and employee count (2,464).
What is FLWPF's 52-week trading range?
Flora Growth Corp (FLWPF) has traded between a 52-week low of $16.09 and a 52-week high of $38.80, with the current price of $26.24 sitting approximately -32% from the annual high. This range represents a spread of $22.71 (141% from low to high), which reflects the volatility the stock has experienced over the past year. The 52-week range is a commonly used technical indicator that helps investors understand whether a stock is trading near the top or bottom of its recent range, and it can inform decisions about entry and exit points. Cannabis stocks in general tend to exhibit higher volatility than broader market indices due to evolving regulations and market sentiment.
How does Flora Growth Corp's valuation compare to cannabis industry peers?
Flora Growth Corp (FLWPF) is valued at a market capitalization of $3.18B with a price-to-sales ratio of 3.12x, and an enterprise value of $3.08B. The EV/Revenue multiple of 20.09x provides a debt-adjusted view of valuation relative to sales, which is particularly important for comparing companies with different capital structures. In the cannabis industry, valuations can vary significantly depending on sector (MSO, LP, Ancillary, etc.), growth rate, and path to profitability. Flora Growth Corp's positive revenue growth of +0.50% YoY may justify a premium relative to slower-growing peers. Investors can use the Cannabismarketcap rankings and comparison tools to benchmark FLWPF against specific competitors on valuation multiples, growth rates, and profitability.
What is Flora Growth Corp's enterprise value?
Flora Growth Corp (FLWPF) has an estimated enterprise value (EV) of $3.08B, which is calculated by taking the market capitalization of $3.18B, adding total debt of $371.1M, and subtracting cash and equivalents of $464.5M. Enterprise value is widely considered a more comprehensive measure of a company's total value than market cap alone because it accounts for the capital structure, including debt obligations and available liquidity. The resulting EV/Revenue ratio of 20.09x allows for an apples-to-apples comparison with peers regardless of differences in leverage. For cannabis companies in particular, where balance sheet health varies dramatically, enterprise value provides a more accurate picture of acquisition cost and relative valuation.
Is Flora Growth Corp stock overvalued or undervalued?
Determining whether Flora Growth Corp (FLWPF) is overvalued or undervalued requires analyzing multiple valuation metrics in context. The current price-to-sales ratio of 3.12x is moderate for the cannabis sector, suggesting the market is pricing in some growth expectations. The stock is currently trading at $26.24, which is -32% from its 52-week high of $38.80, with a gross margin of 7.2% and revenue growth of +0.50% YoY. Investors should consider the company's enterprise value of $3.08B, its cash position of $464.5M, and the broader cannabis industry outlook when forming a valuation opinion. Cannabismarketcap provides all the data needed for a thorough analysis, but this information should not be considered investment advice.
What are the risks of investing in Flora Growth Corp?
Investing in Flora Growth Corp (FLWPF) carries several risks that investors should carefully consider. First, the cannabis industry remains federally illegal in the United States, creating regulatory uncertainty that can impact stock prices, banking access, and tax obligations (notably IRC Section 280E). Second, Flora Growth Corp's balance sheet shows $371.1M in total debt against $464.5M in cash, with an estimated cash runway of approximately 2 months at the current burn rate, which investors should monitor for dilution risk or liquidity concerns. The company has a share dilution rate of 26.5%, meaning the number of shares outstanding has been increasing, which can erode per-share value. Additionally, the stock has shown a 52-week range of $16.09 to $38.80, reflecting meaningful price volatility. As with all cannabis stocks, investors face risks from changing state regulations, competitive pressures, and the evolving legal landscape. This information is for educational purposes only and is not investment advice.
What is Flora Growth Corp's cash position and debt level?
Flora Growth Corp (FLWPF) holds $464.5M in cash and equivalents on its balance sheet, set against $371.1M in total debt. This gives the company a net cash position of $93.5M. At the current rate of cash usage, the company has an estimated cash runway of approximately 2 months before needing additional financing, which could come from operations, debt, or equity issuance. Balance sheet strength is especially important in the cannabis industry, where companies often face limited access to traditional banking and capital markets. Investors should track these metrics over time on Cannabismarketcap to identify trends in cash consumption and debt management.
How many shares outstanding does Flora Growth Corp have?
Flora Growth Corp (FLWPF) currently has 121.1M shares outstanding, which when multiplied by the current stock price of $26.24 gives the company its market capitalization of $3.18B. The share count has been growing at a rate of 26.5% — a metric known as the dilution rate — which is above average for cannabis companies and may be a concern for investors worried about ownership dilution. Share count is important because all per-share metrics (earnings per share, book value per share, etc.) are directly impacted by changes in shares outstanding. Cannabis companies frequently issue new shares to raise capital, so monitoring dilution trends on Cannabismarketcap is recommended for long-term investors.
Does Flora Growth Corp pay a dividend?
Most cannabis companies, including Flora Growth Corp (FLWPF), do not currently pay dividends. The cannabis industry is still in a growth phase, and companies typically reinvest available capital into expanding operations, securing new licenses, building out retail and cultivation infrastructure, and navigating complex regulatory requirements. Additionally, the IRC Section 280E tax burden significantly reduces the free cash flow available for shareholder distributions. Investors in cannabis stocks should generally expect returns to come from capital appreciation rather than dividend income. If Flora Growth Corp initiates a dividend in the future, it would be reported in their SEC filings and reflected on Cannabismarketcap.
How can I research Flora Growth Corp stock before investing?
To research Flora Growth Corp (FLWPF) before investing, start with the company overview on Cannabismarketcap, which provides current price ($26.24), market cap ($3.18B), and key financial metrics. Next, review the full financial statements page for quarterly revenue trends, margins, and balance sheet details. Check the analyst ratings page for Wall Street consensus and price targets, and the technical analysis page for chart patterns and momentum indicators. Compare FLWPF against sector peers using the comparison tool to understand relative valuation. Review recent news coverage for regulatory developments or corporate events. Finally, read the investment analysis page for a comprehensive deep-dive. Cannabis investing carries unique risks including federal illegality, regulatory uncertainty, and limited banking access — always conduct thorough due diligence before making any investment decision.
What does Flora Growth Corp's market cap of $3.18B mean?
Flora Growth Corp's market capitalization of $3.18B represents the total market value of all its outstanding shares (121.1M shares multiplied by the current stock price of $26.24). Market cap is the primary measure investors use to classify companies by size: large-cap companies (over $1B) like Flora Growth Corp are generally considered more established with greater liquidity. In the cannabis sector, market cap is especially important because it determines index weighting, institutional investment eligibility, and often correlates with the company's operational scale and geographic reach. Flora Growth Corp currently ranks # among cannabis stocks tracked on Cannabismarketcap.
What regulatory risks does Flora Growth Corp face?
Flora Growth Corp (FLWPF), like all cannabis companies, faces significant regulatory risks that investors should understand. At the federal level, cannabis remains a Schedule I controlled substance in the United States, which restricts banking access, prevents standard business expense deductions under IRC Section 280E, and creates legal uncertainty. As a licensed producer, Flora Growth Corp operates under national cannabis frameworks that can change with new government policy, affecting production quotas, export capabilities, and market access. Potential catalysts include federal rescheduling (which could ease 280E burdens), the SAFE Banking Act (which would improve banking access), and individual state legalization events. Conversely, regulatory setbacks such as license moratoriums, increased enforcement, or unfavorable tax policy changes pose downside risks. Investors should monitor legislative developments closely using Cannabismarketcap's news and legalization tracker.
More FLWPF Research & Data
FLWPF price, chart & key stats
Revenue, earnings & balance sheet
Quarterly earnings & EPS trends
Historical price & volume chart
Step-by-step buying guide
Side-by-side peer comparison
Detailed investment thesis & outlook
Disclaimer: The information presented on this page is for informational and educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other kind of advice. Cannabismarketcap does not recommend that any security be bought, sold, or held by you. All investments involve risk, and the past performance of a security, industry, sector, market, financial product, trading strategy, or individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. Cannabis stocks carry additional risks including federal illegality, regulatory uncertainty, limited banking access, and high volatility. Always conduct your own research and consider consulting a qualified financial advisor before making investment decisions.